ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹97 Cr | ₹106 Cr | ₹78 Cr | ₹60 Cr | ₹68 Cr |
What is the latest Total Current Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹97 Cr |
| Mar2024 | ₹106 Cr |
| Mar2023 | ₹78 Cr |
| Mar2022 | ₹60 Cr |
| Mar2021 | ₹68 Cr |
How is Total Current Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹97 Cr | -9.03 | |
| Mar2024 | ₹106 Cr | 37.12 | |
| Mar2023 | ₹78 Cr | 28.37 | |
| Mar2022 | ₹60 Cr | -10.56 | |
| Mar2021 | ₹68 Cr | - | |
Compare Total Current Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,902.6 Cr | -6.6% | -7.5% | 12% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -6.6% |
-7.5% |
12% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses